Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute disseminated encephalomyelitis.

R K Garg1

  • 1Department of Neurology, King George's Medical College, Lucknow, India. garg50@yahoo.com

Postgraduate Medical Journal
|February 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case-control study on QEEG as a marker of cognition in depression.

Indian journal of psychiatry·2025
Same author

Complications Encountered with ETV in Infants with Congenital Hydrocephalus.

Neurology India·2022
Same author

Polymorphisms in vitamin D receptor, toll-like receptor 2 and Toll-Like receptor 4 genes links with Dengue susceptibility.

Bioinformation·2021
Same author

Expeditious quest for the best vaccine: the game is on.

QJM : monthly journal of the Association of Physicians·2021
Same author

Cardiovascular complications and its relationship with functional outcomes in Guillain-Barré syndrome.

QJM : monthly journal of the Association of Physicians·2019
Same author

Sample attrition rate of a community study: An analysis of Lucknow urban and rural elderly follow-up over a period of 9 years.

Indian journal of psychiatry·2019
Same journal

Dapagliflozin-induced anaphylactic shock.

Postgraduate medical journal·2026
Same journal

Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

Postgraduate medical journal·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
See all related articles

Acute disseminated encephalomyelitis (ADEM) is an autoimmune CNS disorder. While often monophasic with good prognosis, differentiating it from multiple sclerosis is crucial for treatment.

Area of Science:

  • Neuroimmunology
  • Neurology
  • Demyelinating Diseases

Background:

  • Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disorder of the central nervous system (CNS).
  • It presents with diffuse neurological symptoms and multifocal brain and spinal cord lesions.
  • Pathogenesis is thought to involve a T cell-mediated autoimmune response to myelin basic protein, potentially triggered by infection or vaccination.

Purpose of the Study:

  • To summarize the characteristics, pathogenesis, prognosis, and treatment of ADEM.
  • To highlight the diagnostic challenges in differentiating ADEM from an initial presentation of multiple sclerosis (MS).
  • To discuss the long-term prognosis and the debate surrounding the progression of ADEM to MS.

Main Methods:

  • Review of current literature on ADEM.

Related Experiment Videos

  • Analysis of clinical presentation, neuroimaging findings, and immunological markers.
  • Comparison of ADEM with multiple sclerosis, focusing on diagnostic criteria and prognostic outcomes.

    • Main Results:

    • ADEM is characterized by multifocal white matter lesions and typically has a favorable long-term prognosis.
    • Distinguishing ADEM from the first attack of MS is clinically challenging but essential for appropriate management.
    • Methylprednisolone is the primary treatment; immunoglobulins, plasmapheresis, or cytotoxic drugs are used if initial therapy fails.

    Conclusions:

    • ADEM is a distinct monophasic demyelinating illness with a generally good prognosis.
    • Accurate differentiation from multiple sclerosis is critical for patient management and therapeutic decisions.
    • While some studies suggest a proportion of ADEM patients may develop MS, this is not consistently supported by all follow-up data, particularly from developing countries.